nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—CYP2E1—Fingolimod—multiple sclerosis	0.11	0.179	CbGbCtD
Citalopram—CYP2D6—Fingolimod—multiple sclerosis	0.0526	0.0854	CbGbCtD
Citalopram—CYP2E1—Mitoxantrone—multiple sclerosis	0.0519	0.0842	CbGbCtD
Citalopram—ABCB1—Methylprednisolone—multiple sclerosis	0.0359	0.0584	CbGbCtD
Citalopram—CYP3A4—Fingolimod—multiple sclerosis	0.0334	0.0543	CbGbCtD
Citalopram—CYP2C19—Prednisone—multiple sclerosis	0.027	0.0438	CbGbCtD
Citalopram—CYP2E1—Dexamethasone—multiple sclerosis	0.0269	0.0437	CbGbCtD
Citalopram—CYP2B6—Dexamethasone—multiple sclerosis	0.0265	0.0431	CbGbCtD
Citalopram—ABCB1—Mitoxantrone—multiple sclerosis	0.0262	0.0426	CbGbCtD
Citalopram—ABCB1—Betamethasone—multiple sclerosis	0.0234	0.038	CbGbCtD
Citalopram—ABCB1—Prednisolone—multiple sclerosis	0.0231	0.0375	CbGbCtD
Citalopram—ABCB1—Prednisone—multiple sclerosis	0.0218	0.0354	CbGbCtD
Citalopram—CYP3A4—Methylprednisolone—multiple sclerosis	0.0215	0.035	CbGbCtD
Citalopram—CYP2C19—Dexamethasone—multiple sclerosis	0.0169	0.0274	CbGbCtD
Citalopram—CYP3A4—Triamcinolone—multiple sclerosis	0.0163	0.0265	CbGbCtD
Citalopram—CYP3A4—Mitoxantrone—multiple sclerosis	0.0157	0.0255	CbGbCtD
Citalopram—CYP3A4—Betamethasone—multiple sclerosis	0.014	0.0227	CbGbCtD
Citalopram—CYP3A4—Prednisolone—multiple sclerosis	0.0138	0.0224	CbGbCtD
Citalopram—ABCB1—Dexamethasone—multiple sclerosis	0.0136	0.0221	CbGbCtD
Citalopram—CYP3A4—Prednisone—multiple sclerosis	0.013	0.0212	CbGbCtD
Citalopram—CYP2D6—Dexamethasone—multiple sclerosis	0.0128	0.0208	CbGbCtD
Citalopram—ABCB1—Methotrexate—multiple sclerosis	0.0109	0.0177	CbGbCtD
Citalopram—CYP3A4—Dexamethasone—multiple sclerosis	0.00815	0.0132	CbGbCtD
Citalopram—SLC6A3—nerve—multiple sclerosis	0.00214	0.0809	CbGeAlD
Citalopram—SLC6A2—nerve—multiple sclerosis	0.00173	0.0653	CbGeAlD
Citalopram—SLC6A3—brainstem—multiple sclerosis	0.00092	0.0347	CbGeAlD
Citalopram—HTR2C—brainstem—multiple sclerosis	0.000889	0.0336	CbGeAlD
Citalopram—SLC6A4—brainstem—multiple sclerosis	0.000843	0.0318	CbGeAlD
Citalopram—SLC6A2—brainstem—multiple sclerosis	0.000742	0.028	CbGeAlD
Citalopram—ADRA1A—brainstem—multiple sclerosis	0.00069	0.026	CbGeAlD
Citalopram—HTR2C—medulla oblongata—multiple sclerosis	0.00062	0.0234	CbGeAlD
Citalopram—SLC6A3—midbrain—multiple sclerosis	0.000586	0.0221	CbGeAlD
Citalopram—SLC6A3—spinal cord—multiple sclerosis	0.000572	0.0216	CbGeAlD
Citalopram—HTR2C—midbrain—multiple sclerosis	0.000567	0.0214	CbGeAlD
Citalopram—HTR2C—spinal cord—multiple sclerosis	0.000553	0.0209	CbGeAlD
Citalopram—SLC6A4—midbrain—multiple sclerosis	0.000537	0.0203	CbGeAlD
Citalopram—SLC6A4—spinal cord—multiple sclerosis	0.000524	0.0198	CbGeAlD
Citalopram—SLC6A2—medulla oblongata—multiple sclerosis	0.000518	0.0195	CbGeAlD
Citalopram—SLC6A3—nervous system—multiple sclerosis	0.000482	0.0182	CbGeAlD
Citalopram—HTR2C—nervous system—multiple sclerosis	0.000466	0.0176	CbGeAlD
Citalopram—SLC6A3—central nervous system—multiple sclerosis	0.000464	0.0175	CbGeAlD
Citalopram—SLC6A3—cerebellum—multiple sclerosis	0.000454	0.0171	CbGeAlD
Citalopram—HTR2C—central nervous system—multiple sclerosis	0.000449	0.0169	CbGeAlD
Citalopram—SLC6A4—nervous system—multiple sclerosis	0.000442	0.0167	CbGeAlD
Citalopram—CHRM1—nervous system—multiple sclerosis	0.00044	0.0166	CbGeAlD
Citalopram—SLC6A4—central nervous system—multiple sclerosis	0.000425	0.016	CbGeAlD
Citalopram—CHRM1—central nervous system—multiple sclerosis	0.000424	0.016	CbGeAlD
Citalopram—CYP2D6—brainstem—multiple sclerosis	0.000406	0.0153	CbGeAlD
Citalopram—SLC6A2—nervous system—multiple sclerosis	0.000389	0.0147	CbGeAlD
Citalopram—SLC6A2—central nervous system—multiple sclerosis	0.000374	0.0141	CbGeAlD
Citalopram—SLC6A3—brain—multiple sclerosis	0.000368	0.0139	CbGeAlD
Citalopram—ADRA1A—nervous system—multiple sclerosis	0.000362	0.0136	CbGeAlD
Citalopram—CYP2E1—medulla oblongata—multiple sclerosis	0.000358	0.0135	CbGeAlD
Citalopram—HTR2C—brain—multiple sclerosis	0.000356	0.0134	CbGeAlD
Citalopram—ADRA1A—central nervous system—multiple sclerosis	0.000348	0.0131	CbGeAlD
Citalopram—ADRA1A—cerebellum—multiple sclerosis	0.00034	0.0128	CbGeAlD
Citalopram—SLC6A4—brain—multiple sclerosis	0.000338	0.0127	CbGeAlD
Citalopram—CHRM1—brain—multiple sclerosis	0.000336	0.0127	CbGeAlD
Citalopram—CYP2E1—spinal cord—multiple sclerosis	0.000319	0.012	CbGeAlD
Citalopram—SLC6A2—brain—multiple sclerosis	0.000297	0.0112	CbGeAlD
Citalopram—CYP2B6—nervous system—multiple sclerosis	0.000287	0.0108	CbGeAlD
Citalopram—ABCB1—retina—multiple sclerosis	0.000282	0.0106	CbGeAlD
Citalopram—HRH1—nervous system—multiple sclerosis	0.00028	0.0106	CbGeAlD
Citalopram—ADRA1A—brain—multiple sclerosis	0.000276	0.0104	CbGeAlD
Citalopram—CYP2B6—central nervous system—multiple sclerosis	0.000276	0.0104	CbGeAlD
Citalopram—HRH1—central nervous system—multiple sclerosis	0.000269	0.0102	CbGeAlD
Citalopram—CYP2E1—nervous system—multiple sclerosis	0.000269	0.0101	CbGeAlD
Citalopram—CYP2E1—central nervous system—multiple sclerosis	0.000259	0.00977	CbGeAlD
Citalopram—CYP2E1—cerebellum—multiple sclerosis	0.000253	0.00955	CbGeAlD
Citalopram—CYP2B6—brain—multiple sclerosis	0.000219	0.00827	CbGeAlD
Citalopram—CYP3A4—nervous system—multiple sclerosis	0.000216	0.00817	CbGeAlD
Citalopram—HRH1—brain—multiple sclerosis	0.000214	0.00807	CbGeAlD
Citalopram—CYP2D6—nervous system—multiple sclerosis	0.000213	0.00804	CbGeAlD
Citalopram—CYP3A4—central nervous system—multiple sclerosis	0.000208	0.00786	CbGeAlD
Citalopram—CYP2E1—brain—multiple sclerosis	0.000206	0.00776	CbGeAlD
Citalopram—CYP2D6—central nervous system—multiple sclerosis	0.000205	0.00774	CbGeAlD
Citalopram—ABCB1—medulla oblongata—multiple sclerosis	0.000204	0.00769	CbGeAlD
Citalopram—CYP2D6—cerebellum—multiple sclerosis	0.0002	0.00756	CbGeAlD
Citalopram—ABCB1—midbrain—multiple sclerosis	0.000186	0.00703	CbGeAlD
Citalopram—ABCB1—spinal cord—multiple sclerosis	0.000182	0.00686	CbGeAlD
Citalopram—CYP2D6—brain—multiple sclerosis	0.000163	0.00614	CbGeAlD
Citalopram—ABCB1—nervous system—multiple sclerosis	0.000153	0.00578	CbGeAlD
Citalopram—ABCB1—central nervous system—multiple sclerosis	0.000147	0.00557	CbGeAlD
Citalopram—ABCB1—cerebellum—multiple sclerosis	0.000144	0.00544	CbGeAlD
Citalopram—ABCB1—brain—multiple sclerosis	0.000117	0.00442	CbGeAlD
Citalopram—Skin disorder—Methylprednisolone—multiple sclerosis	9.33e-05	0.000311	CcSEcCtD
Citalopram—Malnutrition—Prednisone—multiple sclerosis	9.32e-05	0.000311	CcSEcCtD
Citalopram—Erythema—Prednisone—multiple sclerosis	9.32e-05	0.000311	CcSEcCtD
Citalopram—Hyperhidrosis—Triamcinolone—multiple sclerosis	9.31e-05	0.00031	CcSEcCtD
Citalopram—Agranulocytosis—Methotrexate—multiple sclerosis	9.31e-05	0.00031	CcSEcCtD
Citalopram—Hyperhidrosis—Methylprednisolone—multiple sclerosis	9.29e-05	0.00031	CcSEcCtD
Citalopram—Convulsion—Dexamethasone—multiple sclerosis	9.28e-05	0.000309	CcSEcCtD
Citalopram—Convulsion—Betamethasone—multiple sclerosis	9.28e-05	0.000309	CcSEcCtD
Citalopram—Hypertension—Dexamethasone—multiple sclerosis	9.24e-05	0.000308	CcSEcCtD
Citalopram—Hypertension—Betamethasone—multiple sclerosis	9.24e-05	0.000308	CcSEcCtD
Citalopram—Asthenia—Mitoxantrone—multiple sclerosis	9.16e-05	0.000305	CcSEcCtD
Citalopram—Myalgia—Dexamethasone—multiple sclerosis	9.11e-05	0.000304	CcSEcCtD
Citalopram—Myalgia—Betamethasone—multiple sclerosis	9.11e-05	0.000304	CcSEcCtD
Citalopram—Anxiety—Betamethasone—multiple sclerosis	9.08e-05	0.000303	CcSEcCtD
Citalopram—Anxiety—Dexamethasone—multiple sclerosis	9.08e-05	0.000303	CcSEcCtD
Citalopram—Discomfort—Betamethasone—multiple sclerosis	9.01e-05	0.0003	CcSEcCtD
Citalopram—Discomfort—Dexamethasone—multiple sclerosis	9.01e-05	0.0003	CcSEcCtD
Citalopram—Haemoglobin—Methotrexate—multiple sclerosis	9e-05	0.0003	CcSEcCtD
Citalopram—Hypotension—Methylprednisolone—multiple sclerosis	8.98e-05	0.000299	CcSEcCtD
Citalopram—Pain—Prednisolone—multiple sclerosis	8.95e-05	0.000298	CcSEcCtD
Citalopram—Hepatitis—Methotrexate—multiple sclerosis	8.95e-05	0.000298	CcSEcCtD
Citalopram—Haemorrhage—Methotrexate—multiple sclerosis	8.95e-05	0.000298	CcSEcCtD
Citalopram—Pharyngitis—Methotrexate—multiple sclerosis	8.88e-05	0.000296	CcSEcCtD
Citalopram—Urinary tract disorder—Methotrexate—multiple sclerosis	8.84e-05	0.000295	CcSEcCtD
Citalopram—Vision blurred—Prednisone—multiple sclerosis	8.79e-05	0.000293	CcSEcCtD
Citalopram—Urethral disorder—Methotrexate—multiple sclerosis	8.77e-05	0.000292	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	8.77e-05	0.000292	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	8.75e-05	0.000292	CcSEcCtD
Citalopram—Oedema—Dexamethasone—multiple sclerosis	8.74e-05	0.000291	CcSEcCtD
Citalopram—Oedema—Betamethasone—multiple sclerosis	8.74e-05	0.000291	CcSEcCtD
Citalopram—Anaphylactic shock—Dexamethasone—multiple sclerosis	8.74e-05	0.000291	CcSEcCtD
Citalopram—Anaphylactic shock—Betamethasone—multiple sclerosis	8.74e-05	0.000291	CcSEcCtD
Citalopram—Diarrhoea—Mitoxantrone—multiple sclerosis	8.73e-05	0.000291	CcSEcCtD
Citalopram—Insomnia—Triamcinolone—multiple sclerosis	8.71e-05	0.00029	CcSEcCtD
Citalopram—Insomnia—Methylprednisolone—multiple sclerosis	8.69e-05	0.00029	CcSEcCtD
Citalopram—Infection—Dexamethasone—multiple sclerosis	8.68e-05	0.000289	CcSEcCtD
Citalopram—Infection—Betamethasone—multiple sclerosis	8.68e-05	0.000289	CcSEcCtD
Citalopram—Ill-defined disorder—Prednisone—multiple sclerosis	8.65e-05	0.000288	CcSEcCtD
Citalopram—Paraesthesia—Triamcinolone—multiple sclerosis	8.65e-05	0.000288	CcSEcCtD
Citalopram—Feeling abnormal—Prednisolone—multiple sclerosis	8.63e-05	0.000288	CcSEcCtD
Citalopram—Paraesthesia—Methylprednisolone—multiple sclerosis	8.63e-05	0.000288	CcSEcCtD
Citalopram—Visual impairment—Methotrexate—multiple sclerosis	8.63e-05	0.000287	CcSEcCtD
Citalopram—Anaemia—Prednisone—multiple sclerosis	8.62e-05	0.000287	CcSEcCtD
Citalopram—Shock—Dexamethasone—multiple sclerosis	8.6e-05	0.000286	CcSEcCtD
Citalopram—Shock—Betamethasone—multiple sclerosis	8.6e-05	0.000286	CcSEcCtD
Citalopram—Dyspnoea—Triamcinolone—multiple sclerosis	8.59e-05	0.000286	CcSEcCtD
Citalopram—Nervous system disorder—Dexamethasone—multiple sclerosis	8.57e-05	0.000286	CcSEcCtD
Citalopram—Nervous system disorder—Betamethasone—multiple sclerosis	8.57e-05	0.000286	CcSEcCtD
Citalopram—Agitation—Prednisone—multiple sclerosis	8.57e-05	0.000286	CcSEcCtD
Citalopram—Thrombocytopenia—Dexamethasone—multiple sclerosis	8.56e-05	0.000285	CcSEcCtD
Citalopram—Thrombocytopenia—Betamethasone—multiple sclerosis	8.56e-05	0.000285	CcSEcCtD
Citalopram—Tachycardia—Dexamethasone—multiple sclerosis	8.53e-05	0.000284	CcSEcCtD
Citalopram—Tachycardia—Betamethasone—multiple sclerosis	8.53e-05	0.000284	CcSEcCtD
Citalopram—Angioedema—Prednisone—multiple sclerosis	8.52e-05	0.000284	CcSEcCtD
Citalopram—Dyspepsia—Triamcinolone—multiple sclerosis	8.48e-05	0.000282	CcSEcCtD
Citalopram—Erythema multiforme—Methotrexate—multiple sclerosis	8.46e-05	0.000282	CcSEcCtD
Citalopram—Dyspepsia—Methylprednisolone—multiple sclerosis	8.46e-05	0.000282	CcSEcCtD
Citalopram—Hyperhidrosis—Dexamethasone—multiple sclerosis	8.45e-05	0.000281	CcSEcCtD
Citalopram—Hyperhidrosis—Betamethasone—multiple sclerosis	8.45e-05	0.000281	CcSEcCtD
Citalopram—Malaise—Prednisone—multiple sclerosis	8.41e-05	0.00028	CcSEcCtD
Citalopram—Vertigo—Prednisone—multiple sclerosis	8.38e-05	0.000279	CcSEcCtD
Citalopram—Eye disorder—Methotrexate—multiple sclerosis	8.37e-05	0.000279	CcSEcCtD
Citalopram—Syncope—Prednisone—multiple sclerosis	8.36e-05	0.000279	CcSEcCtD
Citalopram—Tinnitus—Methotrexate—multiple sclerosis	8.35e-05	0.000278	CcSEcCtD
Citalopram—Anorexia—Dexamethasone—multiple sclerosis	8.33e-05	0.000278	CcSEcCtD
Citalopram—Anorexia—Betamethasone—multiple sclerosis	8.33e-05	0.000278	CcSEcCtD
Citalopram—Urticaria—Prednisolone—multiple sclerosis	8.32e-05	0.000277	CcSEcCtD
Citalopram—Cardiac disorder—Methotrexate—multiple sclerosis	8.31e-05	0.000277	CcSEcCtD
Citalopram—Fatigue—Triamcinolone—multiple sclerosis	8.3e-05	0.000277	CcSEcCtD
Citalopram—Fatigue—Methylprednisolone—multiple sclerosis	8.28e-05	0.000276	CcSEcCtD
Citalopram—Pain—Triamcinolone—multiple sclerosis	8.24e-05	0.000274	CcSEcCtD
Citalopram—Loss of consciousness—Prednisone—multiple sclerosis	8.19e-05	0.000273	CcSEcCtD
Citalopram—Hypotension—Betamethasone—multiple sclerosis	8.16e-05	0.000272	CcSEcCtD
Citalopram—Hypotension—Dexamethasone—multiple sclerosis	8.16e-05	0.000272	CcSEcCtD
Citalopram—Angiopathy—Methotrexate—multiple sclerosis	8.12e-05	0.000271	CcSEcCtD
Citalopram—Vomiting—Mitoxantrone—multiple sclerosis	8.12e-05	0.00027	CcSEcCtD
Citalopram—Immune system disorder—Methotrexate—multiple sclerosis	8.09e-05	0.000269	CcSEcCtD
Citalopram—Convulsion—Prednisone—multiple sclerosis	8.08e-05	0.000269	CcSEcCtD
Citalopram—Mediastinal disorder—Methotrexate—multiple sclerosis	8.07e-05	0.000269	CcSEcCtD
Citalopram—Hypertension—Prednisone—multiple sclerosis	8.05e-05	0.000268	CcSEcCtD
Citalopram—Rash—Mitoxantrone—multiple sclerosis	8.05e-05	0.000268	CcSEcCtD
Citalopram—Dermatitis—Mitoxantrone—multiple sclerosis	8.04e-05	0.000268	CcSEcCtD
Citalopram—Chills—Methotrexate—multiple sclerosis	8.03e-05	0.000268	CcSEcCtD
Citalopram—Headache—Mitoxantrone—multiple sclerosis	8e-05	0.000266	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	7.96e-05	0.000265	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	7.96e-05	0.000265	CcSEcCtD
Citalopram—Arthralgia—Prednisone—multiple sclerosis	7.94e-05	0.000265	CcSEcCtD
Citalopram—Myalgia—Prednisone—multiple sclerosis	7.94e-05	0.000265	CcSEcCtD
Citalopram—Feeling abnormal—Triamcinolone—multiple sclerosis	7.94e-05	0.000264	CcSEcCtD
Citalopram—Feeling abnormal—Methylprednisolone—multiple sclerosis	7.92e-05	0.000264	CcSEcCtD
Citalopram—Anxiety—Prednisone—multiple sclerosis	7.91e-05	0.000264	CcSEcCtD
Citalopram—Alopecia—Methotrexate—multiple sclerosis	7.91e-05	0.000264	CcSEcCtD
Citalopram—Insomnia—Dexamethasone—multiple sclerosis	7.9e-05	0.000263	CcSEcCtD
Citalopram—Insomnia—Betamethasone—multiple sclerosis	7.9e-05	0.000263	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	7.88e-05	0.000263	CcSEcCtD
Citalopram—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	7.86e-05	0.000262	CcSEcCtD
Citalopram—Paraesthesia—Dexamethasone—multiple sclerosis	7.85e-05	0.000261	CcSEcCtD
Citalopram—Paraesthesia—Betamethasone—multiple sclerosis	7.85e-05	0.000261	CcSEcCtD
Citalopram—Discomfort—Prednisone—multiple sclerosis	7.84e-05	0.000261	CcSEcCtD
Citalopram—Mental disorder—Methotrexate—multiple sclerosis	7.84e-05	0.000261	CcSEcCtD
Citalopram—Erythema—Methotrexate—multiple sclerosis	7.79e-05	0.00026	CcSEcCtD
Citalopram—Malnutrition—Methotrexate—multiple sclerosis	7.79e-05	0.00026	CcSEcCtD
Citalopram—Hypersensitivity—Prednisolone—multiple sclerosis	7.72e-05	0.000257	CcSEcCtD
Citalopram—Dyspepsia—Betamethasone—multiple sclerosis	7.69e-05	0.000256	CcSEcCtD
Citalopram—Dyspepsia—Dexamethasone—multiple sclerosis	7.69e-05	0.000256	CcSEcCtD
Citalopram—Urticaria—Triamcinolone—multiple sclerosis	7.65e-05	0.000255	CcSEcCtD
Citalopram—Urticaria—Methylprednisolone—multiple sclerosis	7.63e-05	0.000254	CcSEcCtD
Citalopram—Dysgeusia—Methotrexate—multiple sclerosis	7.63e-05	0.000254	CcSEcCtD
Citalopram—Body temperature increased—Triamcinolone—multiple sclerosis	7.61e-05	0.000254	CcSEcCtD
Citalopram—Oedema—Prednisone—multiple sclerosis	7.61e-05	0.000254	CcSEcCtD
Citalopram—Anaphylactic shock—Prednisone—multiple sclerosis	7.61e-05	0.000254	CcSEcCtD
Citalopram—Abdominal pain—Methylprednisolone—multiple sclerosis	7.6e-05	0.000253	CcSEcCtD
Citalopram—Decreased appetite—Dexamethasone—multiple sclerosis	7.6e-05	0.000253	CcSEcCtD
Citalopram—Decreased appetite—Betamethasone—multiple sclerosis	7.6e-05	0.000253	CcSEcCtD
Citalopram—Nausea—Mitoxantrone—multiple sclerosis	7.58e-05	0.000253	CcSEcCtD
Citalopram—Infection—Prednisone—multiple sclerosis	7.56e-05	0.000252	CcSEcCtD
Citalopram—Gastrointestinal disorder—Betamethasone—multiple sclerosis	7.54e-05	0.000251	CcSEcCtD
Citalopram—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	7.54e-05	0.000251	CcSEcCtD
Citalopram—Back pain—Methotrexate—multiple sclerosis	7.54e-05	0.000251	CcSEcCtD
Citalopram—Fatigue—Betamethasone—multiple sclerosis	7.53e-05	0.000251	CcSEcCtD
Citalopram—Fatigue—Dexamethasone—multiple sclerosis	7.53e-05	0.000251	CcSEcCtD
Citalopram—Shock—Prednisone—multiple sclerosis	7.49e-05	0.000249	CcSEcCtD
Citalopram—Pain—Dexamethasone—multiple sclerosis	7.47e-05	0.000249	CcSEcCtD
Citalopram—Pain—Betamethasone—multiple sclerosis	7.47e-05	0.000249	CcSEcCtD
Citalopram—Nervous system disorder—Prednisone—multiple sclerosis	7.46e-05	0.000249	CcSEcCtD
Citalopram—Tachycardia—Prednisone—multiple sclerosis	7.43e-05	0.000247	CcSEcCtD
Citalopram—Skin disorder—Prednisone—multiple sclerosis	7.39e-05	0.000246	CcSEcCtD
Citalopram—Hyperhidrosis—Prednisone—multiple sclerosis	7.36e-05	0.000245	CcSEcCtD
Citalopram—Vision blurred—Methotrexate—multiple sclerosis	7.34e-05	0.000245	CcSEcCtD
Citalopram—Anorexia—Prednisone—multiple sclerosis	7.25e-05	0.000242	CcSEcCtD
Citalopram—Ill-defined disorder—Methotrexate—multiple sclerosis	7.23e-05	0.000241	CcSEcCtD
Citalopram—Anaemia—Methotrexate—multiple sclerosis	7.2e-05	0.00024	CcSEcCtD
Citalopram—Feeling abnormal—Betamethasone—multiple sclerosis	7.2e-05	0.00024	CcSEcCtD
Citalopram—Feeling abnormal—Dexamethasone—multiple sclerosis	7.2e-05	0.00024	CcSEcCtD
Citalopram—Gastrointestinal pain—Betamethasone—multiple sclerosis	7.15e-05	0.000238	CcSEcCtD
Citalopram—Gastrointestinal pain—Dexamethasone—multiple sclerosis	7.15e-05	0.000238	CcSEcCtD
Citalopram—Hypersensitivity—Triamcinolone—multiple sclerosis	7.1e-05	0.000236	CcSEcCtD
Citalopram—Hypersensitivity—Methylprednisolone—multiple sclerosis	7.08e-05	0.000236	CcSEcCtD
Citalopram—Malaise—Methotrexate—multiple sclerosis	7.03e-05	0.000234	CcSEcCtD
Citalopram—Vertigo—Methotrexate—multiple sclerosis	7e-05	0.000233	CcSEcCtD
Citalopram—Leukopenia—Methotrexate—multiple sclerosis	6.97e-05	0.000232	CcSEcCtD
Citalopram—Urticaria—Dexamethasone—multiple sclerosis	6.94e-05	0.000231	CcSEcCtD
Citalopram—Urticaria—Betamethasone—multiple sclerosis	6.94e-05	0.000231	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Prednisone—multiple sclerosis	6.93e-05	0.000231	CcSEcCtD
Citalopram—Dizziness—Prednisolone—multiple sclerosis	6.92e-05	0.000231	CcSEcCtD
Citalopram—Asthenia—Triamcinolone—multiple sclerosis	6.91e-05	0.00023	CcSEcCtD
Citalopram—Abdominal pain—Dexamethasone—multiple sclerosis	6.91e-05	0.00023	CcSEcCtD
Citalopram—Abdominal pain—Betamethasone—multiple sclerosis	6.91e-05	0.00023	CcSEcCtD
Citalopram—Body temperature increased—Betamethasone—multiple sclerosis	6.91e-05	0.00023	CcSEcCtD
Citalopram—Body temperature increased—Dexamethasone—multiple sclerosis	6.91e-05	0.00023	CcSEcCtD
Citalopram—Asthenia—Methylprednisolone—multiple sclerosis	6.89e-05	0.00023	CcSEcCtD
Citalopram—Insomnia—Prednisone—multiple sclerosis	6.88e-05	0.000229	CcSEcCtD
Citalopram—Paraesthesia—Prednisone—multiple sclerosis	6.83e-05	0.000228	CcSEcCtD
Citalopram—Pruritus—Triamcinolone—multiple sclerosis	6.81e-05	0.000227	CcSEcCtD
Citalopram—Cough—Methotrexate—multiple sclerosis	6.8e-05	0.000227	CcSEcCtD
Citalopram—Pruritus—Methylprednisolone—multiple sclerosis	6.8e-05	0.000227	CcSEcCtD
Citalopram—Convulsion—Methotrexate—multiple sclerosis	6.75e-05	0.000225	CcSEcCtD
Citalopram—Dyspepsia—Prednisone—multiple sclerosis	6.7e-05	0.000223	CcSEcCtD
Citalopram—Arthralgia—Methotrexate—multiple sclerosis	6.63e-05	0.000221	CcSEcCtD
Citalopram—Chest pain—Methotrexate—multiple sclerosis	6.63e-05	0.000221	CcSEcCtD
Citalopram—Myalgia—Methotrexate—multiple sclerosis	6.63e-05	0.000221	CcSEcCtD
Citalopram—Decreased appetite—Prednisone—multiple sclerosis	6.61e-05	0.00022	CcSEcCtD
Citalopram—Rash—Prednisolone—multiple sclerosis	6.6e-05	0.00022	CcSEcCtD
Citalopram—Dermatitis—Prednisolone—multiple sclerosis	6.6e-05	0.00022	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	6.59e-05	0.00022	CcSEcCtD
Citalopram—Diarrhoea—Methylprednisolone—multiple sclerosis	6.57e-05	0.000219	CcSEcCtD
Citalopram—Fatigue—Prednisone—multiple sclerosis	6.56e-05	0.000219	CcSEcCtD
Citalopram—Headache—Prednisolone—multiple sclerosis	6.56e-05	0.000219	CcSEcCtD
Citalopram—Discomfort—Methotrexate—multiple sclerosis	6.55e-05	0.000218	CcSEcCtD
Citalopram—Constipation—Prednisone—multiple sclerosis	6.51e-05	0.000217	CcSEcCtD
Citalopram—Confusional state—Methotrexate—multiple sclerosis	6.41e-05	0.000214	CcSEcCtD
Citalopram—Dizziness—Triamcinolone—multiple sclerosis	6.37e-05	0.000212	CcSEcCtD
Citalopram—Anaphylactic shock—Methotrexate—multiple sclerosis	6.36e-05	0.000212	CcSEcCtD
Citalopram—Dizziness—Methylprednisolone—multiple sclerosis	6.35e-05	0.000212	CcSEcCtD
Citalopram—Infection—Methotrexate—multiple sclerosis	6.32e-05	0.000211	CcSEcCtD
Citalopram—Feeling abnormal—Prednisone—multiple sclerosis	6.27e-05	0.000209	CcSEcCtD
Citalopram—Asthenia—Betamethasone—multiple sclerosis	6.27e-05	0.000209	CcSEcCtD
Citalopram—Asthenia—Dexamethasone—multiple sclerosis	6.27e-05	0.000209	CcSEcCtD
Citalopram—Nervous system disorder—Methotrexate—multiple sclerosis	6.24e-05	0.000208	CcSEcCtD
Citalopram—Thrombocytopenia—Methotrexate—multiple sclerosis	6.23e-05	0.000207	CcSEcCtD
Citalopram—Gastrointestinal pain—Prednisone—multiple sclerosis	6.22e-05	0.000207	CcSEcCtD
Citalopram—Nausea—Prednisolone—multiple sclerosis	6.22e-05	0.000207	CcSEcCtD
Citalopram—Pruritus—Betamethasone—multiple sclerosis	6.18e-05	0.000206	CcSEcCtD
Citalopram—Pruritus—Dexamethasone—multiple sclerosis	6.18e-05	0.000206	CcSEcCtD
Citalopram—Skin disorder—Methotrexate—multiple sclerosis	6.18e-05	0.000206	CcSEcCtD
Citalopram—Hyperhidrosis—Methotrexate—multiple sclerosis	6.15e-05	0.000205	CcSEcCtD
Citalopram—Vomiting—Triamcinolone—multiple sclerosis	6.12e-05	0.000204	CcSEcCtD
Citalopram—Vomiting—Methylprednisolone—multiple sclerosis	6.11e-05	0.000204	CcSEcCtD
Citalopram—Rash—Triamcinolone—multiple sclerosis	6.07e-05	0.000202	CcSEcCtD
Citalopram—Dermatitis—Triamcinolone—multiple sclerosis	6.07e-05	0.000202	CcSEcCtD
Citalopram—Anorexia—Methotrexate—multiple sclerosis	6.06e-05	0.000202	CcSEcCtD
Citalopram—Rash—Methylprednisolone—multiple sclerosis	6.06e-05	0.000202	CcSEcCtD
Citalopram—Dermatitis—Methylprednisolone—multiple sclerosis	6.05e-05	0.000202	CcSEcCtD
Citalopram—Urticaria—Prednisone—multiple sclerosis	6.05e-05	0.000201	CcSEcCtD
Citalopram—Headache—Triamcinolone—multiple sclerosis	6.03e-05	0.000201	CcSEcCtD
Citalopram—Headache—Methylprednisolone—multiple sclerosis	6.02e-05	0.000201	CcSEcCtD
Citalopram—Abdominal pain—Prednisone—multiple sclerosis	6.02e-05	0.0002	CcSEcCtD
Citalopram—Body temperature increased—Prednisone—multiple sclerosis	6.02e-05	0.0002	CcSEcCtD
Citalopram—Diarrhoea—Betamethasone—multiple sclerosis	5.98e-05	0.000199	CcSEcCtD
Citalopram—Diarrhoea—Dexamethasone—multiple sclerosis	5.98e-05	0.000199	CcSEcCtD
Citalopram—Hypotension—Methotrexate—multiple sclerosis	5.94e-05	0.000198	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	5.79e-05	0.000193	CcSEcCtD
Citalopram—Dizziness—Betamethasone—multiple sclerosis	5.78e-05	0.000193	CcSEcCtD
Citalopram—Dizziness—Dexamethasone—multiple sclerosis	5.78e-05	0.000193	CcSEcCtD
Citalopram—Insomnia—Methotrexate—multiple sclerosis	5.75e-05	0.000192	CcSEcCtD
Citalopram—Nausea—Triamcinolone—multiple sclerosis	5.72e-05	0.000191	CcSEcCtD
Citalopram—Paraesthesia—Methotrexate—multiple sclerosis	5.71e-05	0.00019	CcSEcCtD
Citalopram—Nausea—Methylprednisolone—multiple sclerosis	5.71e-05	0.00019	CcSEcCtD
Citalopram—Dyspnoea—Methotrexate—multiple sclerosis	5.67e-05	0.000189	CcSEcCtD
Citalopram—Somnolence—Methotrexate—multiple sclerosis	5.65e-05	0.000188	CcSEcCtD
Citalopram—Hypersensitivity—Prednisone—multiple sclerosis	5.61e-05	0.000187	CcSEcCtD
Citalopram—Dyspepsia—Methotrexate—multiple sclerosis	5.6e-05	0.000187	CcSEcCtD
Citalopram—Vomiting—Dexamethasone—multiple sclerosis	5.56e-05	0.000185	CcSEcCtD
Citalopram—Vomiting—Betamethasone—multiple sclerosis	5.56e-05	0.000185	CcSEcCtD
Citalopram—Decreased appetite—Methotrexate—multiple sclerosis	5.53e-05	0.000184	CcSEcCtD
Citalopram—Rash—Betamethasone—multiple sclerosis	5.51e-05	0.000184	CcSEcCtD
Citalopram—Rash—Dexamethasone—multiple sclerosis	5.51e-05	0.000184	CcSEcCtD
Citalopram—Dermatitis—Betamethasone—multiple sclerosis	5.5e-05	0.000183	CcSEcCtD
Citalopram—Dermatitis—Dexamethasone—multiple sclerosis	5.5e-05	0.000183	CcSEcCtD
Citalopram—Gastrointestinal disorder—Methotrexate—multiple sclerosis	5.49e-05	0.000183	CcSEcCtD
Citalopram—Fatigue—Methotrexate—multiple sclerosis	5.48e-05	0.000183	CcSEcCtD
Citalopram—Headache—Betamethasone—multiple sclerosis	5.47e-05	0.000182	CcSEcCtD
Citalopram—Headache—Dexamethasone—multiple sclerosis	5.47e-05	0.000182	CcSEcCtD
Citalopram—Asthenia—Prednisone—multiple sclerosis	5.46e-05	0.000182	CcSEcCtD
Citalopram—Pain—Methotrexate—multiple sclerosis	5.44e-05	0.000181	CcSEcCtD
Citalopram—Pruritus—Prednisone—multiple sclerosis	5.38e-05	0.000179	CcSEcCtD
Citalopram—Feeling abnormal—Methotrexate—multiple sclerosis	5.24e-05	0.000175	CcSEcCtD
Citalopram—Diarrhoea—Prednisone—multiple sclerosis	5.21e-05	0.000173	CcSEcCtD
Citalopram—Gastrointestinal pain—Methotrexate—multiple sclerosis	5.2e-05	0.000173	CcSEcCtD
Citalopram—Nausea—Dexamethasone—multiple sclerosis	5.19e-05	0.000173	CcSEcCtD
Citalopram—Nausea—Betamethasone—multiple sclerosis	5.19e-05	0.000173	CcSEcCtD
Citalopram—Urticaria—Methotrexate—multiple sclerosis	5.05e-05	0.000168	CcSEcCtD
Citalopram—Dizziness—Prednisone—multiple sclerosis	5.03e-05	0.000168	CcSEcCtD
Citalopram—Abdominal pain—Methotrexate—multiple sclerosis	5.03e-05	0.000168	CcSEcCtD
Citalopram—Body temperature increased—Methotrexate—multiple sclerosis	5.03e-05	0.000168	CcSEcCtD
Citalopram—Vomiting—Prednisone—multiple sclerosis	4.84e-05	0.000161	CcSEcCtD
Citalopram—Rash—Prednisone—multiple sclerosis	4.8e-05	0.00016	CcSEcCtD
Citalopram—Dermatitis—Prednisone—multiple sclerosis	4.79e-05	0.00016	CcSEcCtD
Citalopram—Headache—Prednisone—multiple sclerosis	4.77e-05	0.000159	CcSEcCtD
Citalopram—Hypersensitivity—Methotrexate—multiple sclerosis	4.69e-05	0.000156	CcSEcCtD
Citalopram—Asthenia—Methotrexate—multiple sclerosis	4.56e-05	0.000152	CcSEcCtD
Citalopram—Nausea—Prednisone—multiple sclerosis	4.52e-05	0.000151	CcSEcCtD
Citalopram—Pruritus—Methotrexate—multiple sclerosis	4.5e-05	0.00015	CcSEcCtD
Citalopram—Diarrhoea—Methotrexate—multiple sclerosis	4.35e-05	0.000145	CcSEcCtD
Citalopram—Dizziness—Methotrexate—multiple sclerosis	4.21e-05	0.00014	CcSEcCtD
Citalopram—Vomiting—Methotrexate—multiple sclerosis	4.04e-05	0.000135	CcSEcCtD
Citalopram—Rash—Methotrexate—multiple sclerosis	4.01e-05	0.000134	CcSEcCtD
Citalopram—Dermatitis—Methotrexate—multiple sclerosis	4.01e-05	0.000133	CcSEcCtD
Citalopram—Headache—Methotrexate—multiple sclerosis	3.98e-05	0.000133	CcSEcCtD
Citalopram—Nausea—Methotrexate—multiple sclerosis	3.78e-05	0.000126	CcSEcCtD
Citalopram—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.49e-05	0.000432	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CCR2—multiple sclerosis	2.49e-05	0.000432	CbGpPWpGaD
Citalopram—SLC6A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.48e-05	0.000429	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	2.46e-05	0.000426	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—GPR65—multiple sclerosis	2.46e-05	0.000426	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—POMC—multiple sclerosis	2.45e-05	0.000425	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CCR2—multiple sclerosis	2.45e-05	0.000425	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	2.45e-05	0.000425	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—POMC—multiple sclerosis	2.44e-05	0.000424	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	2.41e-05	0.000418	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—POMC—multiple sclerosis	2.41e-05	0.000417	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—CCL2—multiple sclerosis	2.4e-05	0.000416	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CXCL10—multiple sclerosis	2.4e-05	0.000415	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—CCL2—multiple sclerosis	2.39e-05	0.000415	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—CCL2—multiple sclerosis	2.35e-05	0.000408	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.35e-05	0.000407	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.35e-05	0.000407	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.34e-05	0.000405	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CNR1—multiple sclerosis	2.31e-05	0.0004	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CNR1—multiple sclerosis	2.3e-05	0.000398	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCR1—multiple sclerosis	2.29e-05	0.000397	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CXCL13—multiple sclerosis	2.29e-05	0.000397	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—CXCL10—multiple sclerosis	2.29e-05	0.000396	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CXCL13—multiple sclerosis	2.28e-05	0.000396	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCR1—multiple sclerosis	2.28e-05	0.000396	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	2.28e-05	0.000395	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GPC5—multiple sclerosis	2.28e-05	0.000395	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—CCL5—multiple sclerosis	2.27e-05	0.000394	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CNR1—multiple sclerosis	2.26e-05	0.000392	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCR1—multiple sclerosis	2.25e-05	0.00039	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CXCL13—multiple sclerosis	2.25e-05	0.00039	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—CXCL10—multiple sclerosis	2.24e-05	0.000389	CbGpPWpGaD
Citalopram—SLC6A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.2e-05	0.00038	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	2.18e-05	0.000378	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—SRM—multiple sclerosis	2.18e-05	0.000378	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.15e-05	0.000372	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CXCL10—multiple sclerosis	2.08e-05	0.00036	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CXCL10—multiple sclerosis	2.07e-05	0.000359	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CCL5—multiple sclerosis	2.06e-05	0.000357	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—CCR5—multiple sclerosis	2.05e-05	0.000355	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CXCL10—multiple sclerosis	2.04e-05	0.000353	CbGpPWpGaD
Citalopram—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.02e-05	0.00035	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—IL2RA—multiple sclerosis	2.02e-05	0.00035	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.99e-05	0.000345	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.99e-05	0.000345	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—IL6—multiple sclerosis	1.99e-05	0.000345	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—CCL5—multiple sclerosis	1.97e-05	0.000341	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—CCL5—multiple sclerosis	1.96e-05	0.00034	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.94e-05	0.000337	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.93e-05	0.000335	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—CCL5—multiple sclerosis	1.93e-05	0.000335	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	1.89e-05	0.000328	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—RRM1—multiple sclerosis	1.89e-05	0.000327	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCL3—multiple sclerosis	1.88e-05	0.000326	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	1.88e-05	0.000326	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CCR5—multiple sclerosis	1.86e-05	0.000322	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	1.85e-05	0.000321	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL2RA—multiple sclerosis	1.83e-05	0.000317	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.82e-05	0.000315	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PTGER4—multiple sclerosis	1.81e-05	0.000314	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CCL5—multiple sclerosis	1.79e-05	0.00031	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PGR—multiple sclerosis	1.79e-05	0.000309	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	1.78e-05	0.000309	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.78e-05	0.000308	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—CCR5—multiple sclerosis	1.77e-05	0.000307	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	1.77e-05	0.000306	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	1.75e-05	0.000304	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CXCR3—multiple sclerosis	1.75e-05	0.000304	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—IL2RA—multiple sclerosis	1.75e-05	0.000303	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.74e-05	0.000302	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	1.74e-05	0.000302	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	1.74e-05	0.000302	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.74e-05	0.000301	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CD28—multiple sclerosis	1.73e-05	0.000301	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	1.71e-05	0.000297	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.7e-05	0.000295	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCR2—multiple sclerosis	1.7e-05	0.000295	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCL3—multiple sclerosis	1.63e-05	0.000283	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	1.63e-05	0.000282	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.62e-05	0.000281	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CCR5—multiple sclerosis	1.61e-05	0.000279	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	1.61e-05	0.000278	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	1.6e-05	0.000278	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—POMC—multiple sclerosis	1.6e-05	0.000277	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL2RA—multiple sclerosis	1.59e-05	0.000275	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	1.58e-05	0.000274	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	1.58e-05	0.000274	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CNR1—multiple sclerosis	1.57e-05	0.000272	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PTGER4—multiple sclerosis	1.57e-05	0.000272	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	1.57e-05	0.000271	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	1.56e-05	0.00027	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PGR—multiple sclerosis	1.55e-05	0.000268	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PGR—multiple sclerosis	1.54e-05	0.000267	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	1.54e-05	0.000267	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.54e-05	0.000266	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.54e-05	0.000266	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	1.52e-05	0.000263	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CXCR3—multiple sclerosis	1.52e-05	0.000263	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	1.51e-05	0.000262	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.51e-05	0.000261	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CD28—multiple sclerosis	1.5e-05	0.000261	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.5e-05	0.00026	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CD28—multiple sclerosis	1.5e-05	0.00026	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	1.49e-05	0.000258	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCR2—multiple sclerosis	1.48e-05	0.000256	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	1.48e-05	0.000256	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	1.47e-05	0.000255	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.47e-05	0.000255	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—POMC—multiple sclerosis	1.45e-05	0.000252	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	1.45e-05	0.000251	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.44e-05	0.00025	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CCL2—multiple sclerosis	1.42e-05	0.000246	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CXCL10—multiple sclerosis	1.42e-05	0.000245	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.4e-05	0.000243	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	1.39e-05	0.00024	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	1.38e-05	0.000239	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CNR1—multiple sclerosis	1.36e-05	0.000236	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	1.36e-05	0.000236	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	1.36e-05	0.000235	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	1.34e-05	0.000232	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—TYK2—multiple sclerosis	1.29e-05	0.000224	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.29e-05	0.000223	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—POMC—multiple sclerosis	1.26e-05	0.000218	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	1.25e-05	0.000217	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CD86—multiple sclerosis	1.24e-05	0.000215	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	1.23e-05	0.000214	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	1.23e-05	0.000213	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	1.23e-05	0.000213	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	1.23e-05	0.000213	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	1.22e-05	0.000212	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCL5—multiple sclerosis	1.22e-05	0.000211	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	1.21e-05	0.000209	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	1.2e-05	0.000209	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—IL2—multiple sclerosis	1.18e-05	0.000205	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.18e-05	0.000204	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.17e-05	0.000203	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.16e-05	0.000202	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SPP1—multiple sclerosis	1.13e-05	0.000196	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	1.12e-05	0.000194	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	1.11e-05	0.000193	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.11e-05	0.000193	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	1.1e-05	0.00019	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	1.1e-05	0.00019	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.09e-05	0.000189	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—BCHE—multiple sclerosis	1.08e-05	0.000188	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	1.08e-05	0.000188	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	1.07e-05	0.000186	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CD86—multiple sclerosis	1.07e-05	0.000186	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CD86—multiple sclerosis	1.07e-05	0.000185	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCL5—multiple sclerosis	1.06e-05	0.000183	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	1.05e-05	0.000182	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	1.05e-05	0.000182	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	1.04e-05	0.00018	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	1.02e-05	0.000178	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.02e-05	0.000177	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	1.02e-05	0.000177	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	1.01e-05	0.000174	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1e-05	0.000174	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—APOE—multiple sclerosis	9.99e-06	0.000173	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SPP1—multiple sclerosis	9.78e-06	0.000169	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	9.75e-06	0.000169	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	9.6e-06	0.000166	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCR5—multiple sclerosis	9.51e-06	0.000165	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	9.48e-06	0.000164	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	9.38e-06	0.000162	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	9.35e-06	0.000162	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	9.33e-06	0.000162	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL2—multiple sclerosis	9.3e-06	0.000161	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	9.27e-06	0.000161	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	9.2e-06	0.000159	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.16e-06	0.000159	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	9.13e-06	0.000158	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CD80—multiple sclerosis	9.03e-06	0.000156	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—APOE—multiple sclerosis	8.85e-06	0.000153	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—APOE—multiple sclerosis	8.67e-06	0.00015	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—BCHE—multiple sclerosis	8.66e-06	0.00015	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—APOE—multiple sclerosis	8.65e-06	0.00015	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—APOE—multiple sclerosis	8.63e-06	0.000149	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—POMC—multiple sclerosis	8.58e-06	0.000149	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	8.49e-06	0.000147	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	8.4e-06	0.000145	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	8.21e-06	0.000142	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CD80—multiple sclerosis	7.82e-06	0.000136	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CD80—multiple sclerosis	7.8e-06	0.000135	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	7.68e-06	0.000133	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	7.62e-06	0.000132	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—POMC—multiple sclerosis	7.6e-06	0.000132	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—POMC—multiple sclerosis	7.44e-06	0.000129	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—POMC—multiple sclerosis	7.43e-06	0.000129	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—POMC—multiple sclerosis	7.41e-06	0.000128	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	7.3e-06	0.000126	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCL2—multiple sclerosis	7.27e-06	0.000126	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	7.25e-06	0.000126	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	7.14e-06	0.000124	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	7.12e-06	0.000123	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	7.09e-06	0.000123	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	6.98e-06	0.000121	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ALB—multiple sclerosis	6.93e-06	0.00012	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ALB—multiple sclerosis	6.79e-06	0.000118	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—APOE—multiple sclerosis	6.69e-06	0.000116	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.68e-06	0.000116	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TYK2—multiple sclerosis	6.61e-06	0.000114	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	6.58e-06	0.000114	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—APOE—multiple sclerosis	6.53e-06	0.000113	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	6.48e-06	0.000112	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL2—multiple sclerosis	6.34e-06	0.00011	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	6.31e-06	0.000109	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—APOE—multiple sclerosis	6.15e-06	0.000107	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	6e-06	0.000104	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—POMC—multiple sclerosis	5.74e-06	9.95e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—POMC—multiple sclerosis	5.61e-06	9.71e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL2—multiple sclerosis	5.5e-06	9.53e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL2—multiple sclerosis	5.48e-06	9.49e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL6—multiple sclerosis	5.47e-06	9.48e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	5.45e-06	9.45e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	5.39e-06	9.35e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	5.37e-06	9.3e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	5.34e-06	9.25e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—POMC—multiple sclerosis	5.28e-06	9.15e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ALB—multiple sclerosis	5.24e-06	9.07e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—APOE—multiple sclerosis	5.21e-06	9.03e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MMP9—multiple sclerosis	5.2e-06	9.01e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	5.19e-06	8.99e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ALB—multiple sclerosis	5.11e-06	8.86e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	5.1e-06	8.85e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MYC—multiple sclerosis	4.96e-06	8.6e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	4.95e-06	8.57e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	4.85e-06	8.41e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ALB—multiple sclerosis	4.82e-06	8.35e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—STAT3—multiple sclerosis	4.63e-06	8.02e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	4.61e-06	7.99e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	4.54e-06	7.87e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—POMC—multiple sclerosis	4.48e-06	7.76e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MYC—multiple sclerosis	4.3e-06	7.45e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	4.29e-06	7.43e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MYC—multiple sclerosis	4.28e-06	7.42e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	4.27e-06	7.41e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	4.22e-06	7.31e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	4.21e-06	7.29e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	4.2e-06	7.29e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	4.19e-06	7.26e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	4.13e-06	7.15e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ALB—multiple sclerosis	4.08e-06	7.07e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—APOE—multiple sclerosis	4.02e-06	6.97e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL6—multiple sclerosis	3.73e-06	6.46e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—POMC—multiple sclerosis	3.45e-06	5.99e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6—multiple sclerosis	3.23e-06	5.6e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6—multiple sclerosis	3.22e-06	5.58e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	3.17e-06	5.49e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ALB—multiple sclerosis	3.15e-06	5.46e-05	CbGpPWpGaD
